Ohnishi Shunsuke

オオニシシユンスケ | Ohnishi Shunsuke

Affiliation and department：
Homepage URL (1)： http://kaken.nii.ac.jp/d/r/10443475.ja.html

Research field (1)： Gastroenterology

Research keywords (6)：消化器病学 , 再生医療 , 薬理学 , 発現抑制 , 核酸 , シグナル伝達

Research theme for competitive and other funds (19)：

2022 - 2025 Comprehensive search for host factors related to liver fibrosis mechanisms and development of novel therapeutic strategies
2022 - 2025 ゲル化されたMSC由来エクソソームの内視鏡的粘膜下層剥離術後食道狭窄に対する効果
2021 - 2024 Development of a new minimally invasive treatment for bile duct disease using a bioabsorbable bile duct substitute
2021 - 2024 Examination of the therapeutic effect on inflammatory bowel disease using HSPB6-positive exosomes derived from amnion-derived MSCs
2020 - 2023 Spine-gut relationship in the treatment of spinal cord injury with stem cell

Show all

Papers (153)：

Risako Kohya, Goki Suda, Masatsugu Ohara, Takashi Sasaki, Tomoka Yoda, Naofumi Sakurai, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Shunichi Hosoda, et al. Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 2023. 15. 12
Takashi Sasaki, Goki Suda, Masatsugu Ohara, Shunichi Hosoda, Naoki Kawagishi, Risako Kohya, Tomoka Yoda, Osamu Maehara, Shunsuke Ohnishi, Sonoe Yoshida, et al. Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan. Hepatology research : the official journal of the Japan Society of Hepatology. 2023
Shunichi Hosoda, Goki Suda, Takuya Sho, Koji Ogawa, Megumi Kimura, Zijian Yang, Sonoe Yoshida, Akinori Kubo, Yoshimasa Tokuchi, Takashi Kitagataya, et al. Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment. Liver cancer. 2023. 12. 2. 156-170
Yoshimasa Tokuchi, Goki Suda, Naoki Kawagishi, Masatsugu Ohara, Risako Kohya, Takashi Sasaki, Tomoka Yoda, Osamu Maehara, Shunsuke Ohnishi, Akinori Kubo, et al. Hepatitis C virus eradication by direct-acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low-density lipoprotein cholesterolemia without an increase in body weight. Hepatology research : the official journal of the Japan Society of Hepatology. 2023. 53. 7. 595-606
Zijian Yang, Goki Suda, Osamu Maehara, Masatsugu Ohara, Tomoka Yoda, Takashi Sasaki, Risako Kohya, Sonoe Yoshida, Shunichi Hosoda, Yoshimasa Tokuchi, et al. Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma. Cancers. 2023. 15. 3

ｍore...

MISC (224)：

大西俊介, 福井陽介, 植田陽子, 三宅龍太, 山中彰一郎, 竹田善紀, 中野和俊, 市川麻祐子, 丸山祥代, 赤坂珠理晃, et al. 当科で経験した羊水過多症例の周産期予後の検討. 日本産科婦人科学会雑誌. 2021. 73. 臨増. S-289
市川麻祐子, 三宅龍太, 山中彰一郎, 竹田善紀, 大西俊介, 中野和俊, 吉元千陽, 赤坂珠理晃, 成瀬勝彦, 馬淵誠士, et al. 妊娠中に胎児脳室拡大を指摘された児の予後についての検討. 日本産科婦人科学会雑誌. 2020. 72. 臨増. S-499
大西俊介. 【一般・消化器外科医のためのできる! 漢方】がん化学療法完遂のための漢方食欲不振,嘔気,嘔吐. 臨床外科. 2020. 75. 3. 328-333
木脇佐代子, 清水勇一, 大西俊介, 大野正芳, 楊子健, 霜田佳彦, 井上雅貴, 田中一光, 石川麻倫, 山本桂子, et al. 生体ブタ全周性食道ESD施行後のバルーン拡張時の病理組織学的検討. Gastroenterological Endoscopy (Web). 2020. 62. Supplement1
前原経, 夏井坂光輝, 須田剛生, 大西俊介, 坂本直哉, 武田宏司. FGFR阻害剤およびMEK阻害剤は食道扁平上皮癌(ESCC)がん幹細胞を減少させる. 日本消化管学会雑誌. 2020. 4. Suppl. 301-301

ｍore...

Professional career (1)：

医学博士 (北海道大学)

Work history (3)：

2021/04 - 現在 Hokkaido University Faculty of Pharmaceutical Sciences
2016/04 - 2021/03 Hokkaido University
2010/04 - 北海道大学医学(系)研究科(研究院) 助教

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page